Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-22-005750

Chief Development Officer sold 1,732 shares at an average $4.30 ($7,455)

From the SEC's structured data for this filing

Trades in this filing

LeBel Carl · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-16 Sale : show line 1 in the form −831 $4.43 $3,680 14,070 D
2022-02-17 Sale : show line 2 in the form −901 $4.19 $3,774 13,169 D
Open-market sales · 1,732 sh · avg $4.30 · $7,455

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2022-02-17 Grant or award : show line 3 in the form Restricted Stock Unit +150,000 150,000 150,000 D
Loading xslF345X03/form4.xml…